| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $6.15B | $4.96B | $3.87B |
| YoY Revenue Growth % | +24.1% | +28.3% | — |
| Gross Profit | $1.59B | $1.19B | — |
| Gross Margin % | 25.9% | 24.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $292.0M | $16.0M | -$287.0M |
| Operating Margin % | 4.7% | 0.3% | -7.4% |
| Net Income (GAAP) | $342.0M | $19.0M | -$246.0M |
| EBITDA (Normalized) | $513.5M | $194.6M | -$147.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $661.0M | $360.0M | $135.0M |
| Capital Expenditures (CapEx) | $276.9M | $223.2M | $173.9M |
| Free Cash Flow (FCF) | $384.1M | $136.8M | -$38.9M |
| FCF Margin % | 6.2% | 2.8% | -1.0% |
| Return on Invested Capital (ROIC %) | 18.7% | 1.2% | -3.7% |
| Cash & Short-Term Equivalents | $1.35B | $903.0M | — |
| Total Debt (Short + Long Term) | $459.4M | $388.4M | $2.34B |
| Total Stockholders' Equity | $2.12B | $1.54B | $4.81B |